Study of Nivolumab & Relatlimab in Patients With Microsatellite Stable

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04094688` - Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer	Phase 3
Active, not recruiting	`NCT04474470` - A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer	Phase 1/Phase 2
Recruiting	`NCT06050447` - Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
Recruiting	`NCT05504252` - METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin	Phase 2
Suspended	`NCT04108481` - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer	Phase 1/Phase 2
Completed	`NCT00597506` - Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus	Phase 2
Recruiting	`NCT05902988` - A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer	Phase 1/Phase 2
Completed	`NCT05477836` - Feasibility and Safety of MiWEndo-assisted Colonoscopy	N/A
Recruiting	`NCT05620134` - Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer	Phase 1/Phase 2
Recruiting	`NCT03715933` - Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas	Phase 1
Recruiting	`NCT04870879` - Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors	N/A
Recruiting	`NCT04773769` - Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas	N/A
Recruiting	`NCT04739072` - Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Recruiting	`NCT06134440` - ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study	N/A
Withdrawn	`NCT03708536` - Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma	Phase 3
Withdrawn	`NCT02413853` - Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer	Phase 2
Completed	`NCT00165217` - Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma	Phase 2
Active, not recruiting	`NCT04457284` - Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer	Phase 2
Suspended	`NCT04111172` - A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma	Phase 2
Not yet recruiting	`NCT06118658` - Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations	Phase 2

NCT number	NCT03642067
Study type	Interventional
Source	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	February 12, 2019
Completion date	February 23, 2025

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms